Article

Prognostic value of KRAS exon 2, exon 3 and exon 4 mutations in colorectal cancer patients

2022-11-03

Abstract excerpt

The clinical significance of many RAS-family mutations in colorectal cancer (CRC) remains unclear. The purpose of this study was to investigate the relationship of mutations on an exon basis (i.e., mutations in KRAS exons 2, 3 and 4 and in NRAS) with clinicopathological features and prognosis in CRC. We performed a retrospective cohort study of the medical records and frozen tissue samples of 268 consecutive patie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 53bc5386-c6c5-51fc-85ef-639684c1315c
DOI: 10.21203/rs.3.rs-2197123/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of KRAS exon 2, exon 3 and exon 4 mutations in colorectal cancer patientsDOI 10.21203/rs.3.rs-2197123/v1Read

Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer.Semantic proximity Read

Association between clinicopathological characteristics and RAS mutation in colorectal cancer.Semantic proximity Read

Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations.Semantic proximity Read

Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.Semantic proximity Read

Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancerSemantic proximity Read

Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.Semantic proximity Read

Prognostic Value of KRAS Mutations in Colorectal Cancer PatientsSemantic proximity Read

KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients.Semantic proximity Read

Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients.Semantic proximity Read

Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.Semantic proximity Read

KRAS Mutation Status as a Prognostic Marker and Predictor of Therapy Response in Colorectal Cancer: an NCDB Analysis.Semantic proximity Read

Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.Semantic proximity Read